7,086 research outputs found
Expression of Epstein-Barr virus-encoded BamH1-A rightward transcript 7 microRNA in nasopharyngeal carcinoma cells modulates the responsive to irradiation treatment
published_or_final_versio
The Efficacy of Triamcinolone Acetonide in Keloid Treatment: A Systematic Review and Meta-analysis
published_or_final_versio
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
published_or_final_versio
Extramammary Paget's Disease: 20 years of Experience in Chinese Population
published_or_final_versio
Effectiveness of a parental training programme in enhancing the parent-child relationship and reducing harsh parenting practices and parental stress in preparing children for their transition to primary school: a randomised controlled trial
published_or_final_versio
SARS CoV subunit vaccine: Antibodymediated neutralisation and enhancement
1. A SARS vaccine was produced based on recombinant native full-length Spike-protein trimers (triSpike) and efficient establishment of a vaccination procedure in rodents. 2. Antibody-mediated enhancement of SARS-CoV infection with anti-SARS-CoV Spike immune-serum was observed in vitro. 3. Antibody-mediated infection of SARS-CoV triggers entry into human haematopoietic cells via an FcγR-dependent and ACE2-, pH-, cysteine-protease-independent pathways. 4. The antibody-mediated enhancement phenomenon is not a mandatory component of the humoral immune response elicited by SARS vaccines, as pure neutralising antibody only could be obtained. 5. Occurrence of immune-mediated enhancement of SARS-CoV infection raises safety concerns regarding the use of SARS-CoV vaccine in humans and enables new ways to investigate SARS pathogenesis (tropism and immune response deregulation)
The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis
published_or_final_versio
- …
